Price to Operating Profit (P/OP)
since 2005
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Reportable Segments
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Abbott Laboratories, P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating earnings1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2024 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2023 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 16, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 17, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 15, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 21, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 19, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 23, 2007 | = | ÷ | = | ÷ | |||||||
| Feb 22, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Abbott Laboratories Annual Report.
- Share Price Trend
- The share price exhibited considerable volatility over the observed period. Initially, the price increased from $43.9 in February 2006 to a peak of $56.16 in February 2012, followed by a significant decline to $35.08 in February 2013. Thereafter, the share price generally trended upward, reaching a notable high of $134.92 by February 2025. This upward momentum was, however, accompanied by intermittent fluctuations, particularly declines around 2016 and 2022.
- Operating Profit Per Share (OPPS)
- Operating profit per share showed a mixed pattern. It started at $2.84 in February 2006, plummeted to $1.32 in February 2007, and then fluctuated through subsequent years with peaks in February 2009 ($3.68) and February 2013 ($5.15). In the later years, OPPS showed a recovery trend, peaking again at $4.81 in February 2023 before a slight decline to $3.94 in February 2025. The fluctuations suggest varying operational efficiency or margin pressures across years.
- Price-to-Operating Profit (P/OP) Ratio
- The P/OP ratio exhibited substantial fluctuation, reflecting the interplay between share price and operating profit per share. Early years featured relatively high ratios, particularly 40.49 in 2007, indicating comparatively high valuation relative to profits. The ratio decreased notably to a low of 6.82 in 2013, suggesting undervaluation or higher operating profits. Subsequently, it again increased sharply, peaking at 60.88 in 2018, then showed a declining trend but remained elevated above 20 in recent years. This pattern indicates significant changes in investor perception or profit generation dynamics over time.
- Overall Insights
- The data indicate cyclical behavior in both profitability measures and stock valuation metrics. Share price growth outpaced growth in operating profit per share in some years, as reflected by high P/OP ratios. The volatility in operating profit per share and the P/OP ratio also imply underlying business or market variability. The recent trend towards higher share prices accompanied by moderately stable operating profit suggests improved market confidence or growth prospects. However, the periodic elevated valuation multiples warrant careful analysis of the sustainability of earnings growth.
Comparison to Competitors
Abbott Laboratories, P/OP, long-term trends, comparison to competitors
| Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|
| Feb 21, 2025 | |||||
| Feb 16, 2024 | |||||
| Feb 17, 2023 | |||||
| Feb 18, 2022 | |||||
| Feb 19, 2021 | |||||
| Feb 21, 2020 | |||||
| Feb 22, 2019 | |||||
| Feb 16, 2018 | |||||
| Feb 17, 2017 | |||||
| Feb 19, 2016 | |||||
| Feb 27, 2015 | |||||
| Feb 21, 2014 | |||||
| Feb 15, 2013 | |||||
| Feb 21, 2012 | |||||
| Feb 18, 2011 | |||||
| Feb 19, 2010 | |||||
| Feb 20, 2009 | |||||
| Feb 19, 2008 | |||||
| Feb 23, 2007 | |||||
| Feb 22, 2006 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).